GTY-10558-78738
2 vaccinations
1 coded response
8 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 992 / WA
- Registered
- 2021-02-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-16
Dose 1 — Moderna
-
2021-02-12
Registered in v-safe
-
2021-02-12
Dose 2 — Moderna
- 2021-02-12
-
2021-02-13
Survey response — days 1–6 daily, dose 2MedDRA: Tachycardia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Tachycardia, heart rate >90MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-13
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-18
- 2021-02-19
- 2022-02-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Moderna | |
| 2 | 2021-02-12 | Moderna |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Tachycardia, heart rate >90
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release